Items where authors include "Griffin, C"
Up a levelArticle
Hardt, K, Vandebosch, A, Sadoff, J et al. (285 more authors) (2022) Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2) : results of a randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet Infectious Diseases, 22 (12). pp. 1703-1715. ISSN 1473-3099
Dearnaley, D, Hinder, V, Hijab, A et al. (26 more authors) (2022) Observation versus screening spinal MRI and pre-emptive treatment for spinal cord compression in patients with castration-resistant prostate cancer and spinal metastases in the UK (PROMPTS): an open-label, randomised, controlled, phase 3 trial. The Lancet Oncology. ISSN 1470-2045
Hafeez, S, Webster, A, Hansen, VN et al. (17 more authors) (2020) Protocol for tumour-focused dose-escalated adaptive radiotherapy for the radical treatment of bladder cancer in a multicentre phase II randomised controlled trial (RAIDER): radiotherapy planning and delivery guidance. BMJ Open, 10 (12). ARTN e041005. ISSN 2044-6055
Syndikus, I, Cruickshank, C, Staffurth, J et al. (11 more authors) (2020) PIVOTALboost: A phase III randomised controlled trial of prostate and pelvis versus prostate alone radiotherapy with or without prostate boost (CRUK/16/018). Clinical and Translational Radiation Oncology, 25. pp. 22-28. ISSN 2405-6308
Ockendon, N, Thomas, DHL, Cortina, J et al. (35 more authors) (2018) One hundred priority questions for landscape restoration in Europe. Biological Conservation, 221. pp. 198-208. ISSN 0006-3207
Conference or Workshop Item
Huddart, R, Hafeez, S, Omar, A et al. (22 more authors) (2021) Acute toxicity of hypo- and conventionally-fractionated radiosensitised bladder radiotherapy. In: ESTRO 2021, 28-31 Aug 2021, Madrid, Spain & Online.
Huddart, RA, Lewis, R, Griffin, C et al. (17 more authors) (2020) Patterns of use of chemotherapy with radiotherapy in the treatment of muscle-invasive bladder cancer: Data from the RAIDER randomized trial of adaptive radiotherapy. In: 2020 Genitourinary Cancers Symposium, 13-15 Feb 2020, San Francisco, CA, USA.